Revenue | ₹18.78Cr |
Net Profits | ₹-51.87Cr |
Net Profit Margins | -276.20% |
Sun Pharma Advanced Research Company Ltd’s revenue jumped 2.23% since last year same period to ₹18.78Cr in the Q1 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -30.93% fall in its revenue since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit jumped 45.91% since last year same period to ₹-51.87Cr in the Q1 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 13.22% jump in its net profits since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit margin jumped 47.09% since last year same period to -276.20% in the Q1 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -25.65% fall in its net profit margins since last 3-months.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q1 results 2025 was ₹18.78Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q1 results 2025 was ₹-51.87Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q1 results 2025 was -276.20%.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q1 results 2024 was ₹18.37Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q1 results 2024 was ₹-95.90Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q1 results 2024 was -522.05%.